AzTrials
AzTrials

Rotator Cuff TendinopathyNCT07895810

Comparative Effects of Cyriax Approach With and Without Mobilization With Movement in Shoulder Restriction With Rotator Cuff Tendinopathy

A study testing Cyriax Approach with Mobilization with movement and Cyriax Approach without Mobilization with Movement in people with Rotator Cuff Tendinopathy, run by University of Management and Technology Lahore at 1 site in Pakistan.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This randomized clinical trial compares the effects of the Cyriax approach (deep transverse friction massage) with and without Mulligan Mobilization with Movement (MWM) on pain, range of motion and disability in patients with shoulder restriction due to rotator cuff tendinopathy. Read more about this study

Who is it for?
Ages 30 to 65 years
Conditions the study is for
Rotator Cuff Tendinopathy
What is being tested?
Cyriax Approach with Mobilization with movement and Cyriax Approach without Mobilization with Movement
Could I receive a placebo?
No, everyone receives an active treatment
How many people
38 participants
Where
1 sitePakistan
Study dates
19 Oct 2026to 31 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 30 to 65 years.
  • Both male and female genders.
  • Symptoms in acute (up to 4 weeks) or sub-acute stage (4-6 weeks).
  • Shoulder pain related to the rotator cuff or clinically documented rotator cuff tendinopathy.
  • Pain intensity of 4-6 on the Numeric Pain Rating Scale (NPRS).
  • Limited range of motion of the shoulder, either passive or active.
  • Positive in any two or three impingement/tendinopathy tests: Neer's test, Hawkins-Kennedy test, painful arc test, empty can test and external rotation resistance test.
  • Unilateral involvement of the shoulder

Who cannot join

  • Previous cervical spine or shoulder surgery.
  • Referred pain from the cervical spine or cervical radiculopathy.
  • Other conditions affecting the shoulder joint complex: fractures or dislocations, severe osteoarthritis of the glenohumeral or acromioclavicular joint, adhesive capsulitis, shoulder stiffness and glenohumeral instability.
  • Full-thickness rotator cuff tear or signs that surgery is necessary.
  • Musculoskeletal or systemic inflammatory conditions such as severe osteoarthritis or rheumatoid arthritis.
  • Corticosteroid injections within the last six weeks to three months.
  • Involvement of both shoulders.
  • Concurrent manual therapy or physiotherapy.

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • University of Management & Technology

    Lahore, Punjab Province, 54000

Other trials in Pakistan

About this study

Official title: Comparative Effects of Cyriax Approach With and Without Mobilization With Movement on Pain, Range of Motion and Disability in Shoulder Restriction With Rotator Cuff Tendinopathy

This randomized clinical trial compares the effects of the Cyriax approach (deep transverse friction massage) with and without Mulligan Mobilization with Movement (MWM) on pain, range of motion and disability in patients with shoulder restriction due to rotator cuff tendinopathy. Thirty-eight patients (19 per group) will be recruited by non-probability convenience sampling and randomly allocated to two groups. Both groups will receive laser therapy and conventional physiotherapy; 12 sessions over 4 weeks (3 sessions per week). Outcomes (NPRS, SPADI, Angulus Pro smartphone application) will be measured at baseline and at the 4th week and analyzed using SPSS version 24.

Being tested
Cyriax Approach with Mobilization with movement, Cyriax Approach without Mobilization with Movement
Keywords
Cyriax approach, Mobilization with Movement, Shoulder pain, Shoulder disability, Shoulder restriction, range of motion
Medical subject headings
Shoulder Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cyriax Approach with Mobilization with movementOther

    Cyriax approach (deep transverse friction massage, 10-12 minutes per session) plus Mulligan Mobilization with Movement (sustained posterolateral glide of the humeral head during pain-free active shoulder movement; 3 sets of 10 repetitions with 30-second rest), together with laser therapy and conventional treatment, 3 sessions per week for 4 weeks.

  • Cyriax Approach without Mobilization with MovementOther

    Cyriax approach (deep transverse friction massage, 10-12 minutes per session) together with laser therapy and conventional treatment, 3 sessions per week for 4 weeks.

Study groups in NCT07895810
Study groupRoleWhat they receive
Cyriax approach with Mulligan MobilizationExperimentalCyriax approach (deep transverse friction massage, 10-12 minutes per session) plus Mulligan Mobilization with Movement (sustained posterolateral glide of the humeral head during pain-free active shoulder movement; 3 sets of 10 repetitions with 30-second rest), together with laser therapy and conventional treatment, 3 sessions per week for 4 weeks
Receives: Other: Cyriax Approach with Mobilization with movement
Cyriax approach without Mulligan MobilizationActive comparatorCyriax approach (deep transverse friction massage, 10-12 minutes per session) together with laser therapy and conventional treatment, 3 sessions per week for 4 weeks.
Receives: Other: Cyriax Approach without Mobilization with Movement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Numeric Pain Rating Scale

    11-point self-reported scale: 0 representing no pain and 10 the most severe pain (1-3 mild, 4-6 moderate, 7-10 severe pain). Pain is rated at rest and during activity. Reported ICC 0.74-0.92; MCID about 2-2.5 points

    Measured: Baseline and after 4 weeks

  2. Shoulder Pain and Disability Index

    13-item self-administered questionnaire with a pain subscale (5 items) and a disability subscale (8 items); each item scored 0-10 and total converted to a percentage, higher scores indicating greater disability. Cronbach's alpha about 0.94, test-retest ICC 0.89-0.91; MCID 8-25 points

    Measured: Baseline and after 4 weeks

  3. Smartphone Application

    Used to measure shoulder range of motion (flexion, extension, abduction, adduction, internal and external rotation) from images or video frames; reported test-retest reliability 0.852-0.856

    Measured: Baseline and after 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Oct 2026
  2. Study start19 Oct 2026
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
This randomized clinical trial compares the effects of the Cyriax approach (deep transverse friction massage) with and without Mulligan Mobilization with Movement (MWM) on pain, range of motion and disability in patients with shoulder restriction due to rotator cuff tendinopathy. Thirty-eight patients (19 per group) will be recruited by non-probability convenience sampling and randomly allocated to two groups. Both groups will receive laser therapy and conventional physiotherapy; 12 sessions over 4 weeks (3 sessions per week). Outcomes (NPRS, SPADI, Angulus Pro smartphone application) will be measured at baseline and at the 4th week and analyzed using SPSS version 24.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
38 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07895810
Sponsor's protocol ID
RE-192-2026
Status last verified
Oct 2026
First submitted
19 Oct 2026
Last updated
29 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The results data collected, de-identified individual participant data will be shared.

Questions about this trial

What is this clinical trial studying?

A study testing Cyriax Approach with Mobilization with movement and Cyriax Approach without Mobilization with Movement in people with Rotator Cuff Tendinopathy, run by University of Management and Technology Lahore at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 29 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Numeric Pain Rating Scale (time frame: Baseline and after 4 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in